findmyKOL

Alice Gottlieb, MD

Enriched profile

Professor of Dermatology and Director of Clinical Trials, Department of Dermatology · UT Southwestern Medical Center

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Somers, NY · Northeast · United StatesSpecialtyDermatologyFocusPsoriasis (Derm)+1
Active KOLEmergingfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1985–1994Why? →

Alice Gottlieb is Professor of Dermatology and Director of Clinical Trials, Department of Dermatology at UT Southwestern Medical Center. ClinicalTrials.gov lists 12 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Alice Gottlieb, MD, is Professor of Dermatology and Director of Clinical Trials, Department of Dermatology at UT Southwestern Medical Center, Dallas, TX. The public record shows 40 publications with 1,152 citations (h-index 10), centered on Psoriasis (Derm), Atopic Dermatitis / Eczema. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 37 companies, 5 NIH-funded awards (1985–1994).

  • Top research focus: Psoriasis (Derm)
  • 12 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 37 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Psoriasis / Psoriatic Arthritis10 trialsVitiligo1 trialMetabolic Syndrome1 trialAtopic Dermatitis / Eczema1 trialDermatitis, Contact1 trialDermatitis, Allergic Contact1 trialPsoriasis (Derm)1 trial

Research focus

OpenAlex concept fingerprint
Psoriasis (Derm)Atopic Dermatitis / Eczema

Drugs & molecules

across trials, industry payments and publications
Tremfyageneric · GuselkumabClinical trials—Industry payments91Publications—Bimzelxgeneric · BimekizumabClinical trials—Industry payments55Publications—Cosentyxgeneric · SecukinumabClinical trials—Industry payments45Publications—Spevigogeneric · SpesolimabClinical trials—Industry payments43Publications—Cimziageneric · Certolizumab pegolClinical trials—Industry payments26Publications—Sotyktugeneric · DeucravacitinibClinical trials—Industry payments22Publications—Taltzgeneric · IxekizumabClinical trials—Industry payments17Publications—Rinvoqgeneric · UpadacitinibClinical trials—Industry payments16Publications—Nemluviogeneric · NemolizumabClinical trials—Industry payments12Publications—Otezlageneric · ApremilastClinical trials—Industry payments12Publications—Vtamageneric · TapinarofClinical trials—Industry payments12Publications—Opzelurageneric · RuxolitinibClinical trials—Industry payments10Publications—

Works with

trial sponsors and companies reporting payments
UCB, Inc.Clinical trials—Industry payments128Janssen Biotech, Inc.Clinical trials—Industry payments75E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments68Novartis Pharmaceuticals CorporationClinical trials—Industry payments47Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments40Boehringer Ingelheim International GmbHClinical trials—Industry payments32Abbvie Inc.Clinical trials—Industry payments26Lilly USA, LLCClinical trials—Industry payments20Janssen Scientific Affairs, LLCClinical trials—Industry payments19Galderma Laboratories, L.P.Clinical trials—Industry payments17Eli Lilly and CompanyClinical trials—Industry payments15Incyte CorporationClinical trials—Industry payments15Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments15Amgen Inc.Clinical trials—Industry payments13Dermavant Sciences, Inc.Clinical trials—Industry payments11Tufts Medical CenterClinical trials8Industry payments—LEO Pharma Inc.Clinical trials—Industry payments7Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments7Arcutis Biotherapeutics, Inc.Clinical trials—Industry payments5Almirall LLCClinical trials—Industry payments3Genzyme CorporationClinical trials—Industry payments3Pfizer Inc.Clinical trials—Industry payments3Sanofi Us Services Inc.Clinical trials—Industry payments3Sanofi-Aventis U.S. LLCClinical trials—Industry payments3Ucb SaClinical trials—Industry payments3University of Medicine and Dentistry of New JerseyClinical trials3Industry payments—Ortho Dermatologics, a division of Bausch Health US, LLCClinical trials—Industry payments2AstraZeneca UK LimitedClinical trials—Industry payments1Biofrontera Inc.Clinical trials—Industry payments1Blueprint Medicines CorporationClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
12clinical trials

Investigator role on registered studies.

View trials ↓
37companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 1985–1994

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

37 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    33.9%
    Kinase inhibitor11.8%
    Opzelura100%
    Part D≥24 patients
    Interleukin-17A Antagonist7.5%
    Taltz Autoinjector46%Cosentyx (2 Syringes)33%Cosentyx Sensoready (2 Pens)21%
    Part D<11 patients

    + 5 more classes in this area

  • Dermatology

    30%
    Interleukin-4 Receptor alpha Antagonist20.1%
    Dupixent Pen85%Dupixent Syringe15%
    Part D<11 patients
    Corticosteroid4.9%
    Triamcinolone Acetonide100%
    Part D≥28 patients

    + 2 more classes in this area

  • Anti-infectives

    16.5%
    Azole Antifungal12%
    Ketoconazole100%
    Part D≥38 patients
    Lincosamide Antibacterial4.6%
    Clindamycin Phosphate100%
    Part D≥16 patients
All 7 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

5 NIH research awards on record, funded 1985–1994 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/alice-gottlieb-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/alice-gottlieb-76045114b

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    profiles.utsouthwestern.edu/profile/238936/alice-gottlieb.html

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • ResearchGate

    researchgate.net/scientific-contributions/79660584_Alice_Bendix_Gottlieb_PhD_MD

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Alice-B-Gottlieb-38161119

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/UTSWDerm/posts/please-join-us-in-giving-a-warm-welcome-to-dr-alice-gottlieb-md-phd-who-is-joini/122165157872364587

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • LinkedIn

    linkedin.com/posts/utswderm_facultyfriday-immunodermatology-clinicaltrials-activity-7385015237378215936-v6rP

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    psoriasiscouncil.org/people/alice-gottlieb

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoriasiscouncil.org ↗
  • Other

    psoundbytes.libsyn.com/2024/10

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoundbytes.libsyn.com ↗
  • X / Twitter

    x.com/UTSWDerm/status/1912536698426396799

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    Cornell University Medical College

    1980
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Ph.D.

    Immunology, The Rockefeller University

    1979
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • B.A.

    Chemistry, Brandeis University

    1973
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Triple board-certified in Dermatology

    Rheumatology, and Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aad.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.